The ⁤Link‌ Between⁣ NAD⁺ ⁢ and Brain Health

Nicotinamide adenine dinucleotide ​(NAD⁺) is a ⁣crucial molecule involved in metabolism, energy production, and ‌DNA repair. ‍ Declining NAD⁺ levels are increasingly recognized as ⁤a key factor ‍in brain aging and the advancement of neurodegenerative diseases like Alzheimer’s. Consequently, numerous over-the-counter supplements are marketed with the aim of increasing NAD⁺ levels to‍ potentially slow ⁣aging and improve cellular function.

REV-ERBα and ‌NAD⁺ Levels in Mice

Researchers⁢ investigated the ⁢role of REV-ERBα, a protein⁣ involved in regulating circadian rhythms and metabolism. ​ They⁣ genetically deleted the protein in two groups of mice:⁢ one with a whole-body deletion and another with deletion specifically in‌ astrocytes – supportive glial cells that are a major‌ component⁤ of the central nervous ‌system. Remarkably,⁢ in both groups, NAD⁺ levels in the⁢ brain rose considerably. This suggests that eliminating REV-ERBα, particularly within astrocytes, directly enhances NAD⁺ ⁣production in the‍ brain, opening a potential avenue for future treatments targeting neurodegeneration.

Drug Treatment Protects Against Tau Pathology

Building on these findings,⁤ the ‌research team blocked REV-ERBα using both genetic manipulation and a novel drug. This⁤ drug has previously shown encouraging results in studies related‌ to amyloid-β plaques and Parkinson’s disease (National ‌Center for Biotechnology Information). The combined approach of REV-ERBα‌ inhibition successfully increased NAD⁺ levels and protected the mice from brain damage associated with tau ​protein accumulation. Tau ⁣aggregates are well-established hallmarks of Alzheimer’s disease and ⁤other neurodegenerative disorders,⁤ disrupting brain​ function and ⁢contributing to neuronal death.

The study’s⁣ results ⁤indicate that modulating the body’s internal clock‌ – specifically by⁣ inhibiting REV-ERBα – could⁣ be a ‍novel strategy for protecting the brain, preventing the buildup of tau proteins, and potentially slowing​ or even halting the progression of Alzheimer’s disease.

Understanding Tau Pathology and⁤ Alzheimer’s Disease

Alzheimer’s disease ⁢is a progressive neurodegenerative disorder characterized by cognitive decline ⁤and memory⁣ loss. Two key ​pathological hallmarks of Alzheimer’s are amyloid-β‌ plaques and neurofibrillary tangles ‍formed by the tau protein.While ⁢amyloid-β has been a primary focus of research, ‌increasing evidence points to the critical role of tau in driving neurodegeneration and correlating more closely with cognitive ‍impairment.

Tau protein⁢ normally stabilizes‍ microtubules, which are essential for transporting nutrients⁤ and other molecules within neurons. In Alzheimer’s disease, tau becomes ​abnormally phosphorylated, causing it ‌to detach from microtubules and form ⁢tangled aggregates. these tangles disrupt neuronal‍ transport, leading⁢ to neuronal dysfunction and ultimately ​cell ​death.